Atreca, Inc. (BCEL) Financials

BCEL Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 26.3 million 15.6 million
2023-06-30 115.1 million 70.4 million
2023-03-31 134.4 million 73.5 million
2022-12-31 155.0 million 76.6 million

BCEL Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -17.3 million 2.3 million
2023-06-30 -18.0 million 2.9 million
2023-03-31 -14.5 million 3.2 million
2022-12-31 -15.6 million 3.2 million

BCEL Net Income

No data available :(

BCEL Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 21.4 million - 1.3 million
2023-06-30 38.5 million - 62.2 million
2023-03-31 56.4 million - 63.0 million
2022-12-31 70.5 million - 63.9 million

BCEL Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 39.4 million
2023-06-30 39.2 million
2023-03-31 39.1 million
2022-12-31 39.1 million

BCEL Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 61000 10.4 million 5.4 million -
2023-06-30 21000 12.9 million 6.8 million -
2023-03-31 80000 13.5 million 8.1 million -
2022-12-31 146000 13.8 million 7.5 million -

BCEL Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 80000 1.4 million
2023-06-30 71000 1.7 million
2023-03-31 92000 1.7 million
2022-12-31 20000 1.8 million

BCEL

Price: $0.09

52 week price:
0.05
1.26

Earnings Per Share: -2.50 USD

P/E Ratio: -0.11

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Volume: 154300

Market Capitalization: 3.2 million

Links: